{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:36:03Z","timestamp":1790789763735,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Technology","award":["MOST 103-2320-B-010-025"],"award-info":[{"award-number":["MOST 103-2320-B-010-025"]}]},{"name":"CGMH-NYMU Joint Research","award":["CMRPG2D0211"],"award-info":[{"award-number":["CMRPG2D0211"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.antiviral.2014.12.011","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T09:06:28Z","timestamp":1419411988000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"special_numbering":"C","title":["Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"],"prefix":"10.1016","volume":"115","author":[{"given":"Kai-Wen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ju","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Yin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.12.011_b0005","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.12.011_b0010","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMe1212300","article-title":"Emerging human coronaviruses \u2013 disease potential and preparedness","volume":"367","author":"Anderson","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.12.011_b0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of Middle East respiratory syndrome coronavirus","volume":"369","author":"Assiri","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.12.011_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1747-0285.2008.00679.x","article-title":"Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro)","volume":"72","author":"Bacha","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2014.12.011_b0250","doi-asserted-by":"crossref","first-page":"34667","DOI":"10.1074\/jbc.M114.609644","article-title":"Crystal structure of the MERS coronavirus papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression","volume":"289","author":"Bailey-Elkin","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.12.011_b0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1110\/ps.073186408","article-title":"DNA inhibits catalysis by the carboxyltransferase subunit of acetyl-CoA carboxylase: implications for active site communication","volume":"17","author":"Benson","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2014.12.011_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jinf.2012.10.002","article-title":"Is the discovery of the novel human betacoronavirus 2c EMC\/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?","volume":"65","author":"Chan","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2014.12.011_b0040","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2014.12.011_b0055","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1128\/JVI.02747-06","article-title":"Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/095632020901900402","article-title":"Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme","volume":"19","author":"Chen","year":"2009","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2014.12.011_b0060","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bcp.2008.01.005","article-title":"Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus","volume":"75","author":"Chou","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.abb.2012.02.015","article-title":"Differential domain structure stability of the severe acute respiratory syndrome coronavirus papain-like protease","volume":"520","author":"Chou","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2014.12.011_b0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1107\/S1399004713031040","article-title":"Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease","volume":"70","author":"Chou","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2014.12.011_b0075","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/JVI.02406-09","article-title":"Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases","volume":"84","author":"Clementz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0255","series-title":"Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis","author":"Copeland","year":"2000"},{"key":"10.1016\/j.antiviral.2014.12.011_b0085","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/viro.2002.1685","article-title":"Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA","volume":"304","author":"Diamond","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.12.011_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2013.10.013","article-title":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS","volume":"101","author":"Drexler","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1743-422X-10-359","article-title":"In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection","volume":"10","author":"Eckerle","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.12.011_b0105","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1021\/jm1004489","article-title":"Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation","volume":"53","author":"Ghosh","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.12.011_b0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","article-title":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation","volume":"14","author":"Haagmans","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.12.011_b0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.antiviral.2013.08.015","article-title":"From SARS to MERS: 10years of research on highly pathogenic human coronaviruses","volume":"100","author":"Hilgenfeld","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0120","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hep.25831","article-title":"Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers","volume":"56","author":"Hulskotte","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.12.011_b0125","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3201\/eid1910.130946","article-title":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa","volume":"19","author":"Ithete","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.12.011_b0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc2292","article-title":"Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer","volume":"8","author":"Karran","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2014.12.011_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0140","doi-asserted-by":"crossref","first-page":"11955","DOI":"10.1128\/JVI.02105-13","article-title":"Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors","volume":"87","author":"Kilianski","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0260","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(10)60934-8","article-title":"Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial","volume":"376","author":"Kwo","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.12.011_b0150","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/cmdc.201300134","article-title":"Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications","volume":"8","author":"Lee","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2014.12.011_b0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2014.06.011","article-title":"Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features","volume":"109C","author":"Lei","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0160","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1423-0127-21-54","article-title":"Structural and functional characterization of MERS coronavirus papain-like protease","volume":"21","author":"Lin","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2014.12.011_b0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-3542(02)00013-X","article-title":"Identification of active antiviral compounds against a New York isolate of West Nile virus","volume":"55","author":"Morrey","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0175","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1634\/theoncologist.2014-0178","article-title":"6-Thioguanine: a drug with unrealized potential for cancer therapy","volume":"19","author":"Munshi","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.antiviral.2014.12.011_b0180","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/hep.25700","article-title":"Antiviral or proviral action of mycophenolic acid in hepatitis B infection?","volume":"56","author":"Pan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.12.011_b0185","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1473-3099(13)70164-6","article-title":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study","volume":"13","author":"Reusken","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.12.011_b0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000321483","article-title":"Mycophenolic acid inhibits replication of Japanese encephalitis virus","volume":"57","author":"Sebastian","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.antiviral.2014.12.011_b0195","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.bmc.2011.05.015","article-title":"Synthesis and biological evaluation of alpha-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture","volume":"19","author":"Steuer","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.12.011_b0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.chembiol.2008.04.011","article-title":"A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters","volume":"15","author":"Verschueren","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2009.10.003","article-title":"Fifteen years of HIV protease inhibitors: raising the barrier to resistance","volume":"85","author":"Wensing","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.chembiol.2005.12.008","article-title":"Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease","volume":"13","author":"Wu","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0215","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.12.011_b0220","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1099\/vir.0.059014-0","article-title":"Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease","volume":"95","author":"Yang","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.12.011_b0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0003-9861(64)90184-5","article-title":"Studies on liver alcohol hydrogenase complexes. 3. Multiple inhibition kinetics in the presence of two competitive inhibitors","volume":"106","author":"Yonetani","year":"1964","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.antiviral.2014.12.011_b0230","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.12.011_b0235","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/cr.2008.294","article-title":"PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production","volume":"18","author":"Zheng","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2011.07.014","article-title":"Aprotinin and similar protease inhibitors as drugs against influenza","volume":"92","author":"Zhirnov","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.011_b0245","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.antiviral.2011.08.001","article-title":"Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease","volume":"92","author":"Zhu","year":"2011","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:23Z","timestamp":1759062383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":49,"alternative-id":["S0166354214003623"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}